marketcaparena
Search

    ARQT

    Arcutis Biotherapeutics, Inc.

    Company overview

    Market capitalization
    $3.44B
    Employees
    354
    Latest publication
    2026-09-29
    About Arcutis Biotherapeutics, Inc.

    Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20232023-03-31 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USDQ1 20212021-03-31 · USD
    Total Revenue129,861,000USD129,503,000USD99,219,000USD2,781,000USD0USD0USD0USD0USD
    Cost Of Revenue10,939,000USD11,688,000USD8,685,000USD783,000USD211,000USD192,000USD182,000USD178,000USD
    Gross Profit118,922,000USD117,815,000USD90,534,000USD1,998,000USD-211,000USD-192,000USD-182,000USD-178,000USD
    Research Development20,355,000USD20,451,000USD19,604,000USD35,345,000USD52,558,000USD40,604,000USD30,765,000USD21,631,000USD
    Selling General Administrative82,138,000USD78,977,000USD62,404,000USD5,791,000USD18,728,000USD16,474,000USD11,315,000USD14,454,000USD
    Total Operating Expenses102,493,000USD99,428,000USD82,008,000USD78,263,000USD71,075,000USD56,886,000USD41,898,000USD35,907,000USD
    Operating Income16,429,000USD18,387,000USD8,526,000USD-76,265,000USD-71,286,000USD-57,078,000USD-42,080,000USD-36,085,000USD
    Total Other Income Expense Net-1,284,000USD-522,000USD-1,036,000USD-3,835,000USD-40,000USD98,000USD72,000USD43,000USD
    Interest Income2,279,000USD———————
    Interest Expense3,406,000USD3,001,000USD3,071,000USD7,042,000USD————
    Income Before Tax15,145,000USD17,865,000USD7,490,000USD-80,100,000USD-71,326,000USD-56,980,000USD-42,008,000USD-36,042,000USD
    Income Tax Expense136,000USD470,000USD80,000USD-363,000USD-136,000USD-76,000USD-78,000USD-98,000USD
    Net Income15,009,000USD17,395,000USD7,410,000USD-79,737,000USD-71,326,000USD-56,980,000USD-42,008,000USD-36,042,000USD
    Net Interest Income—5,896,000USD-3,071,000USD-7,042,000USD————
    Tax Provision—470,000USD80,000USD0USD————
    Net Income From Continuing Ops—17,395,000USD7,410,000USD-80,100,000USD-71,326,000USD-56,980,000USD-42,008,000USD-36,042,000USD
    Ebit—20,866,000USD10,561,000USD-73,058,000USD-71,326,000USD-56,980,000USD-42,008,000USD-36,042,000USD
    Ebitda—22,129,000USD11,123,000USD-72,695,000USD-71,115,000USD-56,788,000USD-41,904,000USD-35,944,000USD
    Depreciation And Amortization—1,263,000USD562,000USD363,000USD211,000USD192,000USD104,000USD98,000USD
    Reconciled Depreciation—563,000USD562,000USD363,000USD136,000USD116,000USD104,000USD98,000USD
    Selling And Marketing Expenses———37,127,000USD————
    Non Operating Income Net Other———3,207,000USD-40,000USD98,000USD72,000USD43,000USD
    Net Income Applicable To Common Shares———-80,100,000USD-71,326,000USD-56,980,000USD-42,008,000USD-36,042,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue0USD0USD0USD0USD
    Cost Of Revenue763,000USD455,000USD195,000USD—
    Gross Profit-763,000USD-455,000USD-195,000USD—
    Research Development145,558,000USD115,308,000USD36,522,000USD17,940,000USD
    Selling General Administrative60,971,000USD21,337,000USD6,610,000USD1,795,000USD
    Total Operating Expenses206,529,000USD136,190,000USD42,937,000USD19,735,000USD
    Operating Income-206,529,000USD-136,645,000USD-43,132,000USD-19,735,000USD
    Interest Expense454,000USD0USD0USD0USD
    Net Interest Income0USD0USD——
    Income Before Tax-206,356,000USD-135,678,000USD-41,996,000USD-19,255,000USD
    Income Tax Expense-454,000USD-84,297USD23,140USD-480,000USD
    Tax Provision0USD———
    Net Income-205,902,000USD-135,678,000USD-41,996,000USD-19,255,000USD
    Net Income From Continuing Ops-206,356,000USD-135,678,000USD-41,996,000USD-19,255,000USD
    Ebit-206,529,000USD-135,678,000USD-41,996,000USD-19,735,000USD
    Ebitda-206,075,000USD-135,223,000USD-41,801,000USD-19,255,000USD
    Depreciation And Amortization454,000USD455,000USD195,000USD480,000USD
    Reconciled Depreciation454,000USD122,000USD195,000USD—
    Total Other Income Expense Net173,000USD967,000USD1,136,000USD480,000USD
    Non Operating Income Net Other173,000USD967,000USD——
    Net Income Applicable To Common Shares-206,356,000USD-135,678,000USD-41,996,000USD-19,255,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets488,537,000USD460,003,000USD432,973,000USD370,977,000USD352,433,000USD344,105,000USD348,889,000USD437,354,000USD
    Total Current Assets467,671,000USD438,056,000USD411,232,000USD349,224,000USD332,778,000USD323,671,000USD335,820,000USD423,720,000USD
    Other Current Assets34,770,000USD32,288,000USD21,387,000USD20,621,000USD18,635,000USD23,554,000USD20,273,000USD19,025,000USD
    Other Non Current Assets2,054,000USD———————
    Total Liabilities267,958,000USD———————
    Total Current Liabilities160,340,000USD163,203,000USD129,838,000USD99,770,000USD103,936,000USD91,129,000USD81,013,000USD172,426,000USD
    Other Current Liabilities146,786,000USD———————
    Other Non Current Liabilities431,000USD———————
    Total Stockholder Equity220,579,000USD189,648,000USD189,479,000USD158,073,000USD138,974,000USD142,658,000USD157,541,000USD156,641,000USD
    Total Equity Including Noncontrolling Interest220,579,000USD———————
    Short Long Term Debt6,950,000USD7,950,000USD1,000,000USD1,000,000USD1,000,000USD——99,513,000USD
    Long Term Debt101,950,000USD101,470,000USD107,959,000USD107,498,000USD107,049,000USD107,618,000USD107,203,000USD105,095,000USD
    Net Receivables155,162,000USD144,377,000USD146,229,000USD115,116,000USD106,688,000USD85,415,000USD73,066,000USD60,119,000USD
    Inventory38,879,000USD37,391,000USD22,634,000USD22,419,000USD16,324,000USD16,614,000USD14,526,000USD14,015,000USD
    Property Plant Equipment Net5,125,000USD5,401,000USD5,510,000USD5,782,000USD3,122,000USD3,338,000USD2,994,000USD3,246,000USD
    Intangible Assets13,687,000USD14,250,000USD14,812,000USD15,375,000USD15,937,000USD16,500,000USD9,479,000USD9,792,000USD
    Accounts Payable6,604,000USD18,296,000USD12,528,000USD5,795,000USD15,082,000USD24,529,000USD14,220,000USD19,325,000USD
    Common Stock12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD
    Retained Earnings-1,134,370,000USD-1,149,379,000USD-1,138,084,000USD-1,155,479,000USD-1,162,889,000USD-1,147,003,000USD-1,121,943,000USD-1,111,155,000USD
    Accumulated Other Comprehensive Income-656,000USD-514,000USD-44,000USD-62,000USD-35,000USD-140,000USD-7,000USD533,000USD
    Total Liab—270,355,000USD243,494,000USD212,904,000USD213,459,000USD201,447,000USD191,348,000USD280,713,000USD
    Other Current Liab—136,957,000USD116,310,000USD92,975,000USD87,854,000USD65,758,000USD65,973,000USD52,790,000USD
    Capital Stock—12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD12,000USD
    Cash—34,762,000USD42,907,000USD47,120,000USD73,048,000USD53,104,000USD71,335,000USD134,851,000USD
    Cash And Short Term Investments—224,000,000USD220,982,000USD191,068,000USD191,131,000USD198,088,000USD227,955,000USD330,561,000USD
    Net Debt—79,909,000USD-36,641,000USD66,654,000USD37,115,000USD57,696,000USD39,250,000USD73,327,000USD
    Short Term Debt—7,950,000USD1,000,000USD1,000,000USD1,000,000USD842,000USD820,000USD100,311,000USD
    Short Long Term Debt Total—114,671,000USD6,266,000USD113,774,000USD110,163,000USD110,800,000USD110,585,000USD208,178,000USD
    Short Term Investments—189,238,000USD178,075,000USD143,948,000USD118,083,000USD144,984,000USD156,620,000USD195,710,000USD
    Property Plant Equipment Gross—5,401,000USD8,758,000USD5,782,000USD3,122,000USD3,338,000USD5,558,000USD3,246,000USD
    Common Stock Shares Outstanding—129,365,000shares135,635,000shares132,885,000shares126,997,000shares126,037,000shares120,958,000shares124,302,000shares
    Non Current Assets Total—21,947,000USD21,741,000USD21,753,000USD19,654,999USD20,434,000USD13,069,000USD13,634,000USD
    Non Current Liabilities Total—107,152,000USD113,656,000USD113,134,000USD109,523,000USD110,318,000USD110,335,000USD108,287,000USD
    Non Current Liabilities Other—431,000USD431,000USD360,000USD360,000USD360,000USD570,000USD420,000USD
    Non Currrent Assets Other—2,296,000USD1,419,000USD596,000USD595,999USD596,000USD596,000USD596,000USD
    Net Working Capital—274,853,000USD281,394,000USD249,454,000USD228,842,000USD232,542,000USD254,807,000USD251,294,000USD
    Unclassified Current Liabilities—-7,950,000USD—————-99,513,000USD
    Unclassified Non Current Liabilities—5,251,000USD5,266,000USD5,276,000USD2,114,000USD2,340,000USD2,562,000USD2,772,000USD
    Unclassified Equity—1,339,517,000USD1,327,583,000USD1,313,590,000USD1,301,874,000USD1,289,777,000USD1,279,467,000USD1,267,239,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets432,973,000USD348,889,000USD341,365,000USD449,274,000USD408,152,000USD298,269,000USD107,012,000USD51,098,000USD
    Intangible Assets14,812,000USD9,479,000USD6,438,000USD7,188,000USD————
    Other Current Assets21,387,000USD20,273,000USD19,629,000USD11,845,000USD13,810,000USD7,875,000USD5,209,000USD40,000USD
    Total Liab243,494,000USD191,348,000USD252,698,000USD239,693,000USD110,475,000USD27,648,000USD5,550,000USD75,085,000USD
    Total Stockholder Equity189,479,000USD157,541,000USD88,667,000USD209,581,000USD297,677,000USD270,621,000USD101,462,000USD-23,987,000USD
    Other Current Liab116,310,000USD65,973,000USD33,941,000USD27,666,000USD25,540,000USD15,462,000USD3,654,000USD872,000USD
    Common Stock12,000USD12,000USD9,000USD6,000USD5,000USD4,000USD-166,491,000USD—
    Capital Stock12,000USD12,000USD9,000USD6,000USD5,000USD4,000USD0USD0USD
    Retained Earnings-1,138,084,000USD-1,121,943,000USD-981,904,000USD-719,764,000USD-408,306,000USD-201,950,000USD-66,272,000USD-24,276,000USD
    Cash42,907,000USD71,335,000USD88,398,000USD53,641,000USD97,991,000USD65,082,000USD63,336,000USD39,394,000USD
    Cash And Short Term Investments220,982,000USD227,955,000USD271,861,000USD409,589,000USD388,601,000USD284,441,000USD101,265,000USD50,940,000USD
    Total Current Assets411,232,000USD335,820,000USD330,431,000USD437,406,000USD402,773,000USD292,826,000USD106,474,000USD51,098,000USD
    Total Current Liabilities129,838,000USD81,013,000USD46,668,000USD37,807,000USD33,326,000USD22,602,000USD5,237,000USD2,673,000USD
    Net Debt-36,641,000USD39,250,000USD117,518,000USD148,902,000USD-20,434,000USD-60,118,000USD-63,029,000USD-39,394,000USD
    Short Term Debt1,000,000USD820,000USD735,000USD1,314,000USD433,000USD—178,000USD—
    Short Long Term Debt1,000,000USD———————
    Short Long Term Debt Total6,266,000USD110,585,000USD205,916,000USD202,543,000USD77,557,000USD4,964,000USD307,000USD—
    Long Term Debt107,959,000USD107,203,000USD201,799,000USD197,769,000USD72,350,000USD———
    Short Term Investments178,075,000USD156,620,000USD183,463,000USD355,948,000USD290,610,000USD219,359,000USD37,929,000USD11,546,000USD
    Net Receivables146,229,000USD73,066,000USD25,807,000USD8,458,000USD362,000USD510,000USD145,000USD—
    Inventory22,634,000USD14,526,000USD13,134,000USD7,514,000USD1,180,000USD-510,000USD——
    Accounts Payable12,528,000USD14,220,000USD11,992,000USD8,827,000USD7,353,000USD7,140,000USD1,405,000USD1,801,000USD
    Property Plant Equipment Net5,510,000USD2,994,000USD3,900,000USD4,602,000USD5,301,000USD5,365,000USD491,000USD—
    Property Plant Equipment Gross8,758,000USD5,558,000USD5,824,000USD4,602,000USD5,301,000USD5,365,000USD491,000USD—
    Accumulated Other Comprehensive Income-44,000USD-7,000USD4,000USD-1,086,000USD-255,000USD-2,000USD-1,000USD—
    Common Stock Shares Outstanding127,234,000shares120,958,000shares69,305,000shares55,032,000shares49,406,000shares35,668,000shares38,089,000shares36,236,000shares
    Non Current Assets Total21,741,000USD13,069,000USD10,934,000USD11,868,000USD5,378,999USD5,443,000USD538,000USD0USD
    Non Current Liabilities Total113,656,000USD110,335,000USD206,030,000USD201,886,000USD77,149,000USD5,046,000USD313,000USD72,412,000USD
    Non Current Liabilities Other431,000USD570,000USD849,000USD—4,799,000USD5,046,000USD184,000USD160,000USD
    Non Currrent Assets Other1,419,000USD596,000USD596,000USD78,000USD77,999USD78,000USD47,000USD0USD
    Net Working Capital281,394,000USD254,807,000USD283,763,000USD399,599,000USD369,447,000USD270,224,000USD101,237,000USD48,425,000USD
    Unclassified Non Current Liabilities5,266,000USD2,562,000USD3,382,000USD4,117,000USD———72,092,000USD
    Unclassified Equity1,327,583,000USD1,279,467,000USD1,070,549,000USD930,419,000USD706,228,000USD472,565,000USD334,226,000USD—
    Other Assets———78,000USD78,000USD78,000USD47,000USD—
    Net Tangible Assets———202,393,000USD297,677,000USD270,621,000USD-65,029,000USD-23,987,000USD
    Other Liab————25,000USD82,000USD184,000USD160,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-11,295,000USD17,395,000USD7,410,000USD-15,886,000USD-25,060,000USD-10,788,000USD-41,537,000USD-52,332,000USD
    Depreciation562,000USD563,000USD562,000USD410,000USD3,132,000USD458,000USD1,766,000USD17,000USD
    Stock Based Compensation10,690,000USD10,060,000USD10,037,000USD10,489,000USD9,778,000USD9,393,000USD9,784,000USD12,523,000USD
    Other Non Cash Items493,000USD493,000USD181,000USD183,000USD-543,000USD1,756,000USD-897,000USD-1,060,000USD
    Change To Account Receivables1,852,000USD-31,113,000USD-8,429,000USD-21,272,000USD-12,349,000USD-14,126,000USD-16,609,000USD-5,177,000USD
    Change To Inventory-14,579,000USD-5,000USD-5,891,000USD518,000USD-1,951,000USD-265,000USD611,000USD-633,000USD
    Change In Working Capital1,789,000USD-2,326,000USD-19,944,000USD5,128,000USD-17,687,000USD-1,567,000USD-3,804,000USD-4,267,000USD
    Total Cash From Operating Activities2,239,000USD26,185,000USD-1,754,000USD324,000USD-30,380,000USD-748,000USD-34,688,000USD-45,119,000USD
    Capital Expenditures0USD0USD0USD-78,000USD-608,000USD-5,000,000USD-143,000USD0USD
    Free Cash Flow2,239,000USD26,185,000USD-1,754,000USD246,000USD-30,988,000USD-5,748,000USD-34,831,000USD-45,119,000USD
    Investments-11,332,000USD-34,179,000USD-25,247,000USD17,423,000USD11,750,000USD34,877,000USD84,777,000USD-62,137,000USD
    Total Cashflows From Investing Activities-11,332,000USD-34,179,000USD-25,247,000USD17,423,000USD11,750,000USD34,877,000USD84,777,000USD-62,137,000USD
    Total Cash From Financing Activities1,067,000USD3,722,000USD1,476,000USD1,380,000USD395,000USD-97,411,000USD394,000USD1,455,000USD
    Change In Cash-8,145,000USD-4,213,000USD-25,620,000USD19,327,000USD-18,231,000USD-63,516,000USD50,581,000USD-105,827,000USD
    Begin Period Cash Flow43,215,000USD47,428,000USD73,048,000USD53,721,000USD71,952,000USD135,468,000USD84,887,000USD190,714,000USD
    End Period Cash Flow35,070,000USD43,215,000USD47,428,000USD73,048,000USD53,721,000USD71,952,000USD135,468,000USD84,887,000USD
    Other Cashflows From Financing Activities1,067,000USD3,722,000USD1,476,000USD61,000USD395,000USD-97,411,000USD394,000USD1,455,000USD
    Sale Purchase Of Stock—-1,319,000USD—1,319,000USD——649,000USD—
    Issuance Of Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Unclassified Financing Cash Flow—1,319,000USD——————
    Other Cashflows From Investing Activities———-10,000,000USD———-62,137,000USD
    Unclassified Investing Cash Flow———10,078,000USD—5,000,000USD—62,137,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-16,141,000USD-140,039,000USD-262,140,000USD-311,458,000USD-206,356,000USD-135,678,000USD-41,996,000USD-19,255,000USD
    Depreciation4,667,000USD2,599,000USD1,521,000USD934,000USD454,000USD122,000USD68,000USD195,000USD
    Stock Based Compensation40,364,000USD41,730,000USD38,813,000USD32,682,000USD23,892,000USD7,943,000USD824,000USD151,000USD
    Other Non Cash Items314,000USD-1,368,000USD-1,750,000USD30,302,000USD309,000USD333,000USD-227,000USD2,911,000USD
    Change To Account Receivables-73,163,000USD-47,259,000USD-17,349,000USD-8,458,000USD-8,458,000USD-8,458,000USD-8,458,000USD—
    Change To Inventory-7,329,000USD-400,000USD-5,620,000USD-7,514,000USD-7,514,000USD-7,514,000USD-7,514,000USD—
    Change In Working Capital-34,829,000USD-15,080,000USD-23,501,000USD-10,175,000USD3,620,000USD14,133,000USD-1,505,000USD2,108,000USD
    Total Cash From Operating Activities-5,625,000USD-112,158,000USD-247,057,000USD-257,715,000USD-174,627,000USD-113,033,000USD-42,836,000USD-14,085,000USD
    Capital Expenditures-686,000USD-143,000USD-428,000USD-23,283,000USD-995,000USD-321,000USD-295,000USD-295,000USD
    Free Cash Flow-6,311,000USD-112,301,000USD-247,485,000USD-280,998,000USD-175,622,000USD-113,354,000USD-43,131,000USD-14,085,000USD
    Investments-19,567,000USD28,820,000USD284,619,000USD-87,199,000USD-74,958,000USD-181,503,000USD-26,325,000USD-11,532,000USD
    Total Cashflows From Investing Activities-30,253,000USD28,820,000USD180,232,000USD-87,199,000USD-75,953,000USD-181,824,000USD-26,325,000USD-11,532,000USD
    Net Borrowings0USD-100,000,000USD0USD125,000,000USD72,350,000USD73,987,000USD73,987,000USD73,987,000USD
    Total Cash From Financing Activities6,973,000USD66,202,000USD101,323,000USD301,798,000USD281,947,000USD298,145,000USD93,103,000USD61,593,000USD
    Issuance Of Capital Stock0USD161,682,000USD98,901,000USD176,047,000USD207,490,000USD297,002,000USD94,239,000USD61,207,000USD
    Change In Cash-28,737,000USD-17,371,000USD34,448,000USD-43,116,000USD31,367,000USD3,288,000USD23,942,000USD35,976,000USD
    Begin Period Cash Flow71,952,000USD89,323,000USD54,875,000USD97,991,000USD66,624,000USD63,336,000USD39,394,000USD3,418,000USD
    End Period Cash Flow43,215,000USD71,952,000USD89,323,000USD54,875,000USD97,991,000USD66,624,000USD63,336,000USD39,394,000USD
    Other Cashflows From Investing Activities-10,000,000USD-5,000,000USD—-22,950,000USD-74,958,000USD-181,503,000USD-26,030,000USD-11,532,000USD
    Other Cashflows From Financing Activities6,973,000USD4,520,000USD2,422,000USD751,000USD470,000USD1,143,000USD93,103,000USD61,593,000USD
    Unclassified Investing Cash Flow—5,143,000USD-103,959,000USD46,233,000USD74,958,000USD181,503,000USD26,325,000USD11,827,000USD
    Change To Liabilities———1,565,000USD10,706,000USD17,551,000USD-458,000USD1,264,000USD
    Dividends Paid———-122,813,000USD-72,350,000USD———
    Sale Purchase Of Stock———12,468,000USD842,000USD617,000USD94,504,000USD61,593,000USD
    Unclassified Financing Cash Flow———286,392,000USD280,635,000USD222,398,000USD-168,491,000USD-135,580,000USD
    Cash And Cash Equivalents Changes————31,367,000USD3,288,000USD——
    Unclassified Operating Cash Flow————3,454,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductZORYVECream0.052,926,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductZORYVECream0.1524,231,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductZORYVECream0.335,327,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductZORYVEFoam67,377,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductZORYVECream0.051,360,000USD0001787306-26-000040
    Q1 2026Quarterly · 2026-03-31ProductZORYVECream0.1521,741,000USD0001787306-26-000040
    Q1 2026Quarterly · 2026-03-31ProductZORYVECream0.332,670,000USD0001787306-26-000040
    Q1 2026Quarterly · 2026-03-31ProductZORYVEFoam49,627,000USD0001787306-26-000040
    FY 2025Yearly · 2025-12-31ProductZORYVECream0.05911,000USD0001787306-26-000018
    FY 2025Yearly · 2025-12-31ProductZORYVECream0.1568,274,000USD0001787306-26-000018
    FY 2025Yearly · 2025-12-31ProductZORYVECream0.3120,995,000USD0001787306-26-000018
    FY 2025Yearly · 2025-12-31ProductZORYVEFoam181,892,000USD0001787306-26-000018
    Q3 2025Quarterly · 2025-09-30ProductZORYVECream0.1518,947,000USD0001787306-25-000144
    Q3 2025Quarterly · 2025-09-30ProductZORYVECream0.330,491,000USD0001787306-25-000144
    Q3 2025Quarterly · 2025-09-30ProductZORYVEFoam49,781,000USD0001787306-25-000144
    Q2 2025Quarterly · 2025-06-30ProductZORYVECream0.1514,617,000USD0001787306-25-000124
    Q2 2025Quarterly · 2025-06-30ProductZORYVECream0.327,675,000USD0001787306-25-000124
    Q2 2025Quarterly · 2025-06-30ProductZORYVEFoam39,212,000USD0001787306-25-000124
    Q1 2025Quarterly · 2025-03-31ProductZORYVECream0.050USD0001787306-26-000040
    Q1 2025Quarterly · 2025-03-31ProductZORYVECream0.1510,219,000USD0001787306-26-000040
    Q1 2025Quarterly · 2025-03-31ProductZORYVECream0.323,387,000USD0001787306-26-000040
    Q1 2025Quarterly · 2025-03-31ProductZORYVEFoam30,240,000USD0001787306-26-000040
    FY 2024Yearly · 2024-12-31ProductZORYVECream0.050USD0001787306-26-000018
    FY 2024Yearly · 2024-12-31ProductZORYVECream0.159,921,000USD0001787306-26-000018
    FY 2024Yearly · 2024-12-31ProductZORYVECream0.385,082,000USD0001787306-26-000018
    FY 2024Yearly · 2024-12-31ProductZORYVEFoam71,539,000USD0001787306-26-000018
    Q3 2024Quarterly · 2024-09-30ProductZORYVECream0.152,452,000USD0001787306-25-000144
    Q3 2024Quarterly · 2024-09-30ProductZORYVECream0.322,041,000USD0001787306-25-000144
    Q3 2024Quarterly · 2024-09-30ProductZORYVEFoam20,262,000USD0001787306-25-000144
    Q2 2024Quarterly · 2024-06-30ProductZORYVECream0.150USD0001787306-25-000124
    Q2 2024Quarterly · 2024-06-30ProductZORYVECream0.317,258,000USD0001787306-25-000124
    Q2 2024Quarterly · 2024-06-30ProductZORYVEFoam13,600,000USD0001787306-25-000124
    Q1 2024Quarterly · 2024-03-31ProductZORYVECream15,026,000USD0001787306-25-000092
    Q1 2024Quarterly · 2024-03-31ProductZORYVECream0.150USD0001787306-25-000092
    Q1 2024Quarterly · 2024-03-31ProductZORYVEFoam6,543,000USD0001787306-25-000092
    FY 2023Yearly · 2023-12-31ProductZORYVECream0.050USD0001787306-26-000018
    FY 2023Yearly · 2023-12-31ProductZORYVECream0.150USD0001787306-26-000018
    FY 2023Yearly · 2023-12-31ProductZORYVECream0.329,186,000USD0001787306-26-000018
    FY 2023Yearly · 2023-12-31ProductZORYVEFoam0USD0001787306-26-000018
    FY 2022Yearly · 2022-12-31ProductZORYVECream0.150USD0001787306-25-000029
    FY 2022Yearly · 2022-12-31ProductZORYVECream0.33,686,000USD0001787306-25-000029
    FY 2022Yearly · 2022-12-31ProductZORYVEFoam0USD0001787306-25-000029

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.